BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 23, 2026
Home
»
Newsletters
» BioWorld
BioWorld
April 21, 2008
View Archived Issues
Biotech's 1st Quarter '08 Fails to Fire Up Market
Read More
Influenza Travel Patterns May Enable Longer-Term Forecasts
Read More
AACR Roundup
Read More
Financings Roundup
Read More
Clinic Roundup
Read More
AAN Roundup
Read More
Other News To Note
Read More
Elan-Wyeth Alzheimer's Trial Suspended Due to Skin Lesion
A Phase II trial of the ACC-011 compound for Alzheimer's disease being developed by Elan Corp. plc and Wyeth Pharmaceuticals has been suspended due to a skin lesion observed in a single patient. (BioWorld Today)
Read More
Biotechs Plead Their Case in the Halls of Congress
Read More
Stock Winners and Losers For The Week
Read More
Money Raised By Month
Read More
BioWorld Stock Report For Public Biotechnology Companies
Read More
